Tag: Vaccines
FDA Expected to Allow Mix ‘n’ Match COVID-19 Vaccines
Agency will not recommend one vaccine over another but may say it is preferable to use same booster as the vaccine
Pfizer Sends First Data to FDA on COVID-19 Vaccines for Younger Children
Agency has said it could authorize a vaccine for younger children in a matter of weeks after receipt of trial data
U.S. Appeals Panel Backs New York City Vaccine Mandate for School Staff
This was the second time in recent weeks that the vaccine mandate has been upheld
mRNA-1273 Continues to Be Efficacious at Five Months
Vaccine efficacy was 93.2 percent for preventing COVID-19 illness, 98.2 percent for preventing severe COVID-19
Highest Parental COVID-19 Vaccine Hesitancy Seen Among Most Impacted
Black parents and those of publicly insured children show greatest vaccine hesitancy
Live Attenuated Zoster Vaccine Safe for Patients Receiving TNF Inhibitors
No cases of varicella infection found; cumulative incidence of varicella infection or shingles was 0 percent
Vaccines Effective in Preventing Symptomatic COVID-19 in Health Care Workers
Findings seen even for those at risk for severe disease and racial and ethnic groups disproportionately affected by the pandemic
Pfizer to Ask FDA Soon for Approval of Its COVID-19 Vaccine for Younger Children
Right now, COVID-19 vaccines are only approved for children 12 years and older
Antibodies ID’d in Neonates of Women Vaccinated Against COVID-19
All 36 neonates had high levels of anti-S IgG; in 34 of 36 neonates, levels exceeded 250 U/mL
CDC Endorses Booster Shots for Millions of Americans
Recommendations came just one day after the FDA authorized boosters for several vulnerable groups at least six months after the second dose
